Aulos Bioscience, Inc.
LARKSPUR, CA · Founded 2020 · CIK 0001832335 · Biotech · Private
IL-2 immunotherapeutic molecules for cancer treatment
aulosbio.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $20M
- 2 Form D · Aug 2023
- 38 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 15
- 3 granted · 12 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20202021202220232024
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $15,000,000 | |
| Private capital raised | Form D · SEC | $5,000,000 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2472 | Fulgent Pharma LLC | — | $5.4M |
| 2473 | Kestrel Therapeutics Inc. | — | $21M |
| 2474 | FIBRONOX, L.L.C. | — | — |
| 2475 | Aulos Bioscience, Inc. | — | $20M |
| 2476 | Surf Bio, Inc. | — | $16M |
| 2477 | ImmunGene | — | — |
| 2478 | MABVAX THERAPEUTICS INC | — | $16M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Yechezkel BarenholzDirector
- Anna BatarinaDirector
- Rajesh ChopraDirector
- Michael EhlersDirector · Executive Officer
- Seth HarrisonDirector
- Aron KnickerbockerDirector · Executive Officer
- Yanay OfranDirector · Executive Officer
- Micah PearlmanExecutive Officer
- Leo RedmondExecutive Officer
- Mace RothenbergDirector
- James VasselliExecutive Officer
- Joseph YanchikDirector
Patents
- ANTI-IL-2 Antibody Combinations And Methods Of Use Thereofapplication
- ANTI-IL-2 Antibody Combinations And Methods Of Use Thereofapplication
- ANTI-IL-2 Antibody Combinations And Methods Of Use Thereofapplication
- Engineered ANTI-IL-2 Antibodiesapplication
- Engineered ANTI-IL-2 Antibodiesgranted
- Engineered ANTI-IL-2 Antibodiesgranted
- Methods Of Use Of ANTI-IL-2 Antibodiesapplication
- Methods Of Use Of ANTI-IL-2 Antibodiesapplication
- Engineered ANTI-IL-2 Antibodiesgranted
- Methods Of Use Of ANTI-IL-2 Antibodiesapplication
- Methods Of Use Of ANTI-IL-2 Antibodiesapplication
- Methods Of Use Of ANTI-IL-2 Antibodiesapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.